- Home
- PROK vs SKYX Comparison
PROK vs SKYX Comparison
Compare PROK & SKYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- SKYX
- Stock Information
- Founded
- PROK 2015
- SKYX 2004
- Country
- PROK United States
- SKYX United States
- Employees
- PROK N/A
- SKYX N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- SKYX Building Products
- Sector
- PROK Health Care
- SKYX Consumer Discretionary
- Exchange
- PROK Nasdaq
- SKYX Nasdaq
- Market Cap
- PROK 85.5M
- SKYX 99.2M
- IPO Year
- PROK N/A
- SKYX 2022
- Fundamental
- Price
- PROK $0.70
- SKYX $1.10
- Analyst Decision
- PROK Hold
- SKYX Strong Buy
- Analyst Count
- PROK 3
- SKYX 2
- Target Price
- PROK $3.50
- SKYX $3.50
- AVG Volume (30 Days)
- PROK 1.6M
- SKYX 1.0M
- Earning Date
- PROK 08-08-2025
- SKYX 08-11-2025
- Dividend Yield
- PROK N/A
- SKYX N/A
- EPS Growth
- PROK N/A
- SKYX N/A
- EPS
- PROK N/A
- SKYX N/A
- Revenue
- PROK $306,000.00
- SKYX $87,412,993.00
- Revenue This Year
- PROK $54.34
- SKYX $18.90
- Revenue Next Year
- PROK N/A
- SKYX $29.10
- P/E Ratio
- PROK N/A
- SKYX N/A
- Revenue Growth
- PROK N/A
- SKYX 12.42
- 52 Week Low
- PROK $0.46
- SKYX $0.75
- 52 Week High
- PROK $2.59
- SKYX $2.14
- Technical
- Relative Strength Index (RSI)
- PROK 47.84
- SKYX 40.14
- Support Level
- PROK $0.54
- SKYX $0.97
- Resistance Level
- PROK $0.90
- SKYX $1.11
- Average True Range (ATR)
- PROK 0.13
- SKYX 0.10
- MACD
- PROK -0.02
- SKYX -0.01
- Stochastic Oscillator
- PROK 33.83
- SKYX 30.73
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About SKYX SKYX Platforms Corp.
SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.